The effect of intravenous Vitamin B6 administration in Prevention of nausea and vomiting due to chemotherapy in pediatrics.
Phase 3
- Conditions
- nausea and vomiting.Nausea with vomiting, unspecified
- Registration Number
- IRCT20150119020715N8
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
desire to participate in the study
Children with malignancy who need to chemotherapy
2 to 15 years of age
Exclusion Criteria
Unwilling to participate in the study
patients with Immune deficiency
patients with cardiovascular disease
patients with AIDS
patients with renal failure
patients with diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea and vomiting. Timepoint: The frequency of nausea and vomiting is recorded within 24 hours. Method of measurement: Recorded in checklist.
- Secondary Outcome Measures
Name Time Method